Aug 04, 2023 / 11:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to Alembic Pharmaceuticals Limited Discussion on company's Q1 Unaudited Financial Results Conference Call. We have with us today, Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head Finance; Mr. Jesal Shah, Head Strategy; and Mr. Ajay Kumar Desai, Senior VP Finance.
(Operator Instructions). Please note that this conference is being recorded. I would now like to hand the conference over to Mr. R.K. Baheti. Thank you, and over to you, sir.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thank you. Good evening, everyone. Thank you all for joining the first quarter results conference call. I'm sure you have got to their views by now. Let me briefly take you through the financial numbers.
During the quarter, our total revenue grew 18% to INR 1,486 crores, EBITDA is INR 210 crores, which is 14.1% of sales and grew by 67% before considering nonleaking
Q1 2024 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Aug 04, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers